Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Kinnate Biopharma

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
2018
11-50
San Diego, California, United States

Investment Funding

Last Funding Stage

Series C

Total Funding Amount

195.M

Last Funding Amount

98.M

Last Funding Date

26-08-2020

Startup Stage

M&A

Lead Investors

RA Capital Management, OrbiMed, Fidelity, Vida Ventures, Janus Henderson Investors

Revenue

Less than $1M

People

Founders

Something missing or incorrect on this page? Help us enrich this information